Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
congress
2
×
detroit blog main
detroit top stories
drug prices
2
×
indiana blog main
indiana top stories
life sciences
national
national blog main
2
×
national top stories
new york blog main
new york top stories
pbms
pharmacy benefit managers
pricing
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sanofi
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
2019
abbvie
activism
acute hepatic porphyria
adalimumab
administration
What
drug
advanced
alnylam’s
approval
away
bff
bio
bringing
ceos
conference
dc
deals
devoted
disease
easl
executives
form
gathered
gene
groups
hearing
held
kicked
liver
lower
major
pharma
pharmaceutical
prices
race
rebates
roundup
senate
seven
therapy
today
treat
updates
washington
world's
Language
Current search:
congress
×
" national blog main "
×
" drug prices "
×
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away